Enhanced plasmacytoid dendritic cell antiviral responses after omalizumab

Journal of Allergy and Clinical Immunology

Volumn 141, Issue 5, 2018, Pages 1735-1743.e9

  Gill, Michelle A ^a   Liu, Andrew H ^b   Calatroni, Agustin ^c   Krouse, Rebecca Z ^c   Shao, Baomei ^a   Schiltz, Allison ^b   Gern, James E ^e   Togias, Alkis ^d   Busse, William W ^e  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b University of Colorado Denver and Children s Hospital Colorado   (United States)

^c Rho   (United States)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^e UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

asthma; Fc R ; IFN ; IgE; omalizumab; Plasmacytoid dendritic cells; rhinovirus

Indexed keywords

ALPHA INTERFERON; FC EPSILON RI ALPHA PROTEIN; IMMUNOGLOBULIN E; OMALIZUMAB; PROTEIN; TOLL LIKE RECEPTOR 7; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; ASTHMA; CELL ISOLATION; CHILD; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE EXACERBATION; EX VIVO STUDY; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VIVO STUDY; INFLUENZA VIRUS; MAJOR CLINICAL STUDY; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHINOVIRUS; TREATMENT RESPONSE;

EID: 85030033277     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2017.07.035     Document Type: Article

References (32)

1. Heymann, P.W., Carper, H.T., Murphy, D.D., Platts-Mills, T.A., Patrie, J., McLaughlin, A.P., et al. Viral infections in relation to age, atopy, and season of admission among children hospitalized for wheezing. J Allergy Clin Immunol 114 (2004), 239–247.
2. Green, R.M., Custovic, A., Sanderson, G., Hunter, J., Johnston, S.L., Woodcook, A., Synergism between allergens and viruses and risk of hospital admission with asthma: case-control study. BMJ, 324, 2002, 763.
3. Murray, C.S., Poletti, G., Kebadze, T., Morris, J., Woodcook, A., Johnston, S.L., et al. Study of modifiable risk factors for asthma exacerbations: virus infection and allergen exposure increase the risk of asthma hospital admissions in children. Thorax 61 (2006), 376–382.
4. Schroeder, J.T., Bieneman, A.P., Xiao, H., Chichester, K.L., Vasagar, K., Saini, S., et al. TLR9- and FcepsilonRI-mediated responses oppose one another in plasmacytoid dendritic cells by down-regulating receptor expression. J Immunol 175 (2005), 5724–5731.
5. Gill, M.A., Bajwa, G., George, T.A., Dong, C.C., Dougherty, I.I., Jiang, N., et al. Counterregulation between the FcepsilonRI pathway and antiviral responses in human plasmacytoid dendritic cells. J Immunol 184 (2010), 5999–6006.
6. Durrani, S.R., Montville, D.J., Pratt, A.S., Sahu, S., DeVries, M.K., Rajamanickam, V., et al. Innate immune responses to rhinovirus are reduced by the high-affinity IgE receptor in allergic asthmatic children. J Allergy Clin Immunol 130 (2012), 489–495.
7. Foster, B., Metcalfe, D.D., Prussin, C., Human dendritic cell 1 and dendritic cell 2 subsets express FcepsilonRI: correlation with serum IgE and allergic asthma. J Allergy Clin Immunol 112 (2003), 1132–1138.
8. Prussin, C., Griffith, D.T., Boesel, K.M., Lin, H., Foster, B., Casale, T.B., Omalizumab treatment downregulates dendritic cell FcepsilonRI expression. J Allergy Clin Immunol 112 (2003), 1147–1154.
9. Schroeder, J.T., Bieneman, A.P., Chichester, K.L., Hamilton, R.G., Xiao, H., Saini, S.S., et al. Decreases in human dendritic cell-dependent T(H)2-like responses after acute in vivo IgE neutralization. J Allergy Clin Immunol 125 (2010), 896–901.e6.
10. Teach, S.J., Gill, M.A., Togias, A., Sorkness, C.A., Arbes, S.J. Jr., Calatroni, A., et al. Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost to prevent fall asthma exacerbations. J Allergy Clin Immunol 136 (2015), 1476–1485.
11. Bajwa, G., DeBerardinis, R.J., Shao, B., Hall, B., Farrar, J.D., Gill, M.A., Cutting edge: critical role of glycolysis in human plasmacytoid dendritic cell antiviral responses. J Immunol 196 (2016), 2004–2009.
12. Teach, S.J., Gergen, P.J., Szefler, S.J., Mitchell, H.E., Calatroni, A., Wildfire, J., et al. Seasonal risk factors for asthma exacerbations among inner-city children. J Allergy Clin Immunol 135 (2015), 1465–1473.e5.
13. Hoch, H.E., Calatroni, A., West, J.B., Liu, A.H., Gergen, P.J., Gruchalla, R.S., et al. Predicting fall seasonal asthma exacerbations in inner-city children in the absence and presence of omalizumab therapy. J Allergy Clin Immunol, 2017 [Epub ahead of print].
14. Friedman, J., Hastie, T., Tibshirani, R., Regularization paths for generalized linear models via coordinate descent. J Stat Softw 33 (2010), 1–22.
15. Diebold, S.S., Kaisho, T., Hemmi, H., Akira, S., Reis e Sousa, C., Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303 (2004), 1529–1531.
16. Gilliet, M., Cao, W., Liu, Y.J., Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat Rev Immunol 8 (2008), 594–606.
17. Honda, K., Yanai, H., Negishi, H., Asagiri, M., Sato, M., Mizutani, T., et al. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434 (2005), 772–777.
18. Pestka, S., Krause, C.D., Walter, M.R., Interferons, interferon-like cytokines, and their receptors. Immunol Rev 202 (2004), 8–32.
19. Saini, S.S., MacGlashan, D.W. Jr., Sterbinskym, S.A., Togias, A., Adelman, D.C., Lichtenstein, L.M., et al. Down-regulation of human basophil IgE and FC epsilon RI alpha surface densities and mediator release by anti-IgE-infusions is reversible in vitro and in vivo. J Immunol 162 (1999), 5624–5630.
20. Liu, Y.J., IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu Rev Immunol 23 (2005), 275–306.
21. Huber, J.P., Ramos, H.J., Gill, M.A., Farrar, J.D., Cutting edge: type I IFN reverses human Th2 commitment and stability by suppressing GATA3. J Immunol 185 (2010), 813–817.
22. Djukanovic, R., Harrison, T., Johnston, S.L., Gabbay, F., Wark, P., Thomson, N.C., et al. The effect of inhaled IFN-beta on worsening of asthma symptoms caused by viral infections. A randomized trial. Am J Respir Crit Care Med 190 (2014), 145–154.
23. Cao, W., Rosen, D.B., Ito, T., Bover, L., Bao, M., Watanabe, G., et al. Plasmacytoid dendritic cell-specific receptor ILT7-Fc epsilonRI gamma inhibits Toll-like receptor-induced interferon production. J Exp Med 203 (2006), 1399–1405.
24. Cao, W., Zhang, L., Rosen, D.B., Bover, L., Watanabe, G., Bao, M., et al. BDCA2/Fc epsilon RI gamma complex signals through a novel BCR-like pathway in human plasmacytoid dendritic cells. PLoS Biol, 5, 2007, e248.
25. Bao, M., Hanabuchi, S., Facchinetti, V., Du, Q., Bover, L., Plumas, J., et al. CD2AP/SHIP1 complex positively regulates plasmacytoid dendritic cell receptor signaling by inhibiting the E3 ubiquitin ligase Cbl. J Immunol 189 (2012), 786–792.
26. Ning, S., Pagano, J.S., Barber, G.N., IRF7: activation, regulation, modification and function. Genes Immun 12 (2011), 399–414.
27. Loo, Y.M., Gale, M. Jr., Immune signaling by RIG-I-like receptors. Immunity 34 (2011), 680–692.
28. Lynch, J.P., Werder, R.B., Simpson, J., Loh, Z., Zhang, V., Haque, A., et al. Aeroallergen-induced IL-33 predisposes to respiratory virus-induced asthma by dampening antiviral immunity. J Allergy Clin Immunol 138 (2016), 1326–1337.
29. Roponen, M., Yerkovich, S.T., Hollams, E., Sly, P.D., Holt, P.G., Upham, J.W., Toll-like receptor 7 function is reduced in adolescents with asthma. Eur Respir J 35 (2010), 64–71.
30. Pritchard, A.L., White, O.J., Burel, J.G., Carroll, M.L., Phipps, S., Upham, J.W., Asthma is associated with multiple alterations in anti-viral innate signalling pathways. PLoS One, 9, 2014, e106501.
31. Contoli, M., Ito, K., Padovani, A., Poletti, D., Marku, B., Edwards, M.R., et al. Th2 cytokines impair innate immune responses to rhinovirus in respiratory epithelial cells. Allergy 70 (2015), 910–920.
32. MacGlashan, D. Jr., IgE and FcepsilonRI regulation. Clin Rev Allergy Immunol 29 (2005), 49–60.